GSK’s Asthma Treatment Gets FDA Approval – Bidness Etc


Bidness Etc

GSK's Asthma Treatment Gets FDA Approval
Bidness Etc
Yesterday, GlaxoSmithKline plc (GSK) announced that the Food and Drug Administration (FDA) has given marketing approval for its drug Arnuity Ellipta, developed as an asthma treatment in patients aged 12 and older. Asthma is a lingering lung disease
FDA OKs New Maintenance Asthma Treatment Arnuity ElliptaMedscape
FDA approves GSK asthma medicinePhiladelphia Business Journal (blog)
FDA approves GSK's Arnuity Ellipta for treating asthmaHealio
Monthly Prescribing Reference –News-Medical.net –The Pharma Letter
all 21 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.